Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?
- PMID: 15144238
- PMCID: PMC1133809
- DOI: 10.1042/BJ20031819
Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria?
Abstract
Recent studies by our group and others have disclosed the presence of ceramides in mitochondria, and the activities of ceramide synthase and reverse ceramidase in mitochondria have also been reported. Since a possible contamination with the ER (endoplasmic reticulum)-related compartment MAM (mitochondria-associated membrane) could not be ruled out in previous studies, we have re-investigated the presence of the enzymes of ceramide metabolism in mitochondria and MAM highly purified from rat liver. In the present paper, we show that purified mitochondria as well as MAM are indeed able to generate ceramide in vitro through both ceramide synthase or reverse ceramidase, whereas the latter enzyme activity is barely detectable in microsomes. Moreover, ceramide synthase activities were recovered in outer mitochondrial membranes as well as in inner mitochondrial membranes. Using radiolabelled sphingosine as a substrate, mitochondria could generate ceramide and phytoceramide. However, the in vitro sensitivity of ceramide synthase toward FB1 (fumonisin B1) in mitochondria as well as in MAM was found to depend upon the sphingoid base: whereas dihydrosphingosine N-acyltransferase was inhibited by FB1 in a concentration-dependent manner, FB1 actually activated the ceramide synthase when using sphingosine as a substrate. Acylation of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate, generating ceramide 1-phosphate, was also shown with both subcellular fractions. Moreover, the same difference in sensitivity towards FB1 for the ceramide synthase activities was seen between the two phosphorylated sphingoid bases, raising the possibility that distinct base-specific enzymes may be involved as ceramide synthases. Collectively, these results demonstrate the involvement of mitochondria in the metabolism of ceramides through different pathways, thereby supporting the hypothesis that topology of ceramide formation could determine its function.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i005.gif)
![Figure 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/1133809/bin/bic090i006.gif)
Similar articles
-
The mitochondria-associated endoplasmic-reticulum subcompartment (MAM fraction) of rat liver contains highly active sphingolipid-specific glycosyltransferases.Biochem J. 2003 May 1;371(Pt 3):1013-9. doi: 10.1042/BJ20021834. Biochem J. 2003. PMID: 12578562 Free PMC article.
-
Fumonisin-induced tumor necrosis factor-alpha expression in a porcine kidney cell line is independent of sphingoid base accumulation induced by ceramide synthase inhibition.Toxicol Appl Pharmacol. 2001 Jul 1;174(1):69-77. doi: 10.1006/taap.2001.9189. Toxicol Appl Pharmacol. 2001. PMID: 11437650
-
Self-Protection against the Sphingolipid Biosynthesis Inhibitor Fumonisin B1 Is Conferred by a FUM Cluster-Encoded Ceramide Synthase.mBio. 2020 Jun 16;11(3):e00455-20. doi: 10.1128/mBio.00455-20. mBio. 2020. PMID: 32546615 Free PMC article.
-
Ceramide synthases: roles in cell physiology and signaling.Adv Exp Med Biol. 2010;688:60-71. doi: 10.1007/978-1-4419-6741-1_4. Adv Exp Med Biol. 2010. PMID: 20919646 Review.
-
A Stroll Down the CerS Lane.Adv Exp Med Biol. 2019;1159:49-63. doi: 10.1007/978-3-030-21162-2_4. Adv Exp Med Biol. 2019. PMID: 31502199 Review.
Cited by
-
The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury.Lipids Health Dis. 2024 Mar 2;23(1):68. doi: 10.1186/s12944-024-02019-x. Lipids Health Dis. 2024. PMID: 38431645 Free PMC article.
-
Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle.Elife. 2023 Dec 27;12:RP87340. doi: 10.7554/eLife.87340. Elife. 2023. PMID: 38149844 Free PMC article.
-
MAVI1, an endoplasmic reticulum-localized microprotein, suppresses antiviral innate immune response by targeting MAVS on mitochondrion.Sci Adv. 2023 Sep;9(35):eadg7053. doi: 10.1126/sciadv.adg7053. Epub 2023 Sep 1. Sci Adv. 2023. PMID: 37656786 Free PMC article.
-
Mass Spectrometry Detects Sphingolipid Metabolites for Discovery of New Strategy for Cancer Therapy from the Aspect of Programmed Cell Death.Metabolites. 2023 Jul 20;13(7):867. doi: 10.3390/metabo13070867. Metabolites. 2023. PMID: 37512574 Free PMC article. Review.
-
More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy.Acta Neuropathol. 2023 Sep;146(3):369-385. doi: 10.1007/s00401-023-02601-0. Epub 2023 Jul 8. Acta Neuropathol. 2023. PMID: 37421475 Free PMC article. Review.
References
-
- Hannun Y. A., Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol. 2000;10:73–80. - PubMed
-
- Levade T., Jaffrezou J. P. Signaling sphingomyelinases: which, where, how and why? Biochim. Biophys. Acta. 1999;1438:1–17. - PubMed
-
- Perry D. K., Carton J., Shah A. K., Meredith F., Uhlinger D. J., Hannun Y. A. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem. 2000;275:9078–9084. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources